The changing role of surgery in the diagnosis and treatment of cancer

American Journal of Medicine

Volumn 106, Issue 1, 1999, Pages 81-89

  Mintzer, David ^a,b  

^a PENNSYLVANIA HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; HAIRY CELL LEUKEMIA; HEAD AND NECK CANCER; LYMPHOMA; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CARCINOMA; REVIEW; SARCOMA; SURGICAL INSTRUMENT; SURGICAL TECHNIQUE; TESTIS CANCER;

CHEMOTHERAPY, ADJUVANT; HUMANS; NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 0032983705     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00373-8     Document Type: Review

References (98)

1. Gazelle G.C., Haaga J.R. Imaging-guided percutaneous abdominal biopsy. Oncology. 5:1991;27-38.
2. Fisher B., Redmond C., Fisher E. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. NEJM. 312:1985;674-681.
3. Fisher B., Redmond C., Poisson R., et al. Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. NEJM. 320:1989;822-828.
4. Veronesi U., Saccozzi R., Del Becchio M., et al. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. NEJM. 305:1981;6-11.
5. Harris JR, Lippman ME, Veronesi U, et al. Breast cancer. NEJM 1992:319-328,390-398,473-480.
6. Effects of radiotherapy and surgery in early breast cancer - an overview of the randomized trials. NEJM. 333:1995;1444-1455.
7. Fisher B., Mamounas E.P. Preoperative chemotherapy a model for studying the biology and therapy of primary breast cancer . J Clin Oncol. 13:1995;537-540.
8. Recht A., Houlihan M.J. Axillary lymph nodes and breast cancer. Cancer. 76:1995;1491-1512.
9. Krag D.N., Weaver D.L., Alex J.C., Fairbank J.R. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Onc. 2:1993;335-340.
10. Morrow M., Schnitt S., Harris J. Ductal carcinoma in situ. Harris J.R., Lippman M.E., Morrow M., Hellman S. Diseases of the Breast. 1995;353-373 Lippincott-Raven.
11. Fisher B., Constantino J., Redmond C., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. NEJM. 328:1993;1581-1586.
12. Morrow M., Schnitt S., Harris J. Ductal carcinoma in situ. Harris J.R., Lippman M.E., Morrow M., Hellman S. Diseases of the Breast. 1995;369-373 Lippincott-Raven.
13. Pettine S., Place R., Babu S., Williard W., Kim D., Carter P. Stereotactic breast biopsy is accurate, minimally invasive and cost effective. Am J Surg. 171:1996;474-476.
14. Wallace J.E., Sayler C., McDowell N.G., Moseley H.S. The role of stereotactic biopsy in assessment of nonpalpable breast lesions. Am J Surg. 171:1996;471-473.
15. Hernandez L.E., Connelly P.J., Strickler S.A., Akers M.M., Dunn M.M. Are sterotaxic breast biopsies adequate? Surgery. 116:1994;610-614.
16. Pettine S., Place R., Babu S., Williard W., Kim D., Carter P. Stereotactic breast biopsy is accurate, minimally invasive and cost effective. Am J Surg. 171:1996;474-476.
17. Wallace J.E., Sayler C., McDowell N.G., Moseley H.S. The role of stereotactic biopsy in assessment of nonpalpable breast lesions. Am J Surg. 17:1996;471-473.
18. Hernandez L.E., Connelly P.J., Strickler S.A., Akers M.M., Dunn M.M. Are stereotaxic breast biopsies adequate? Surgery. 116:1994;610-614.
19. Mitnick J.S., Vazquez M.F., Pressman P.I., Harris M.N., Roses D.F. Stereotactic fine-needle aspiration biopsy for the evaluation of nonpalpable breast lesions; report of an experience based on 2,988 cases. Ann Surg Oncol. 3:1996;185-191.
20. Ingle J.M., Krook J.E., Green S.J., et al. Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer. J Clin Oncol. 4:1986;178-185.
21. Buchanan R.B., Blamey R.W., Durrant K.R., et al. A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol. 4:1986;1326-1330.
22. Harvey H.A., Lipton A., Max D.T. Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer. J Clin Oncol. 3:1985;1068-1072.
23. Santen R.J., Worgul T.J., Samojlik E. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. NEJM. 305:1981;545-551.
24. Pappa V.I., Hussain H.K., Reznek R.H., et al. Role of image-guided core-needle biopsy in the management of patients with lymphoma. J Clin Oncol. 14:1996;2427-2430.
25. Ben-Yehuda D., Polliack A., Okon E., et al. Image-guided core-needle biopsy in malignant lymphoma experience with 100 patients that suggests the technique is reliable . J Clin Oncol. 14:1996;2431-2434.
26. Sklar J, Longtine J. The clinical significance of antigen receptor gene rearrangements in lymphoid neoplasia. Cancer 1992;70(suppl):1710-1708.
27. Miller T.P., Jones S.E. Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood. 62:1983;413-418.
28. Connors J.M., Klimo P., Rairey R.N., et al. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med. 107:1987;25-30.
29. Mauch P. Controversies in the management of early stage Hodgkin's disease. Blood. 83:1994;318-329.
30. Spinelli P., Beretta G., Bajetta E., et al. Laparoscopy and lapartomomy combined with bone marrow biopsy in staging Hodgkin's disease. BMJ. 4:1975;554-556.
31. Leflvor A.T., Flowers J.L., Heyman M.R. Laparscopic staging of Hodgkins disease. Surg Oncol. 2:1993;217-220.
32. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. NEJM. 325:1991;1685-1690.
33. Pfister D.G., Strong E., Harrison L., et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol. 9:1991;850-859.
34. Lefebvre J.-L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmoud T. Larynx preservation in pyriform sinus cancer preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial . J Nat Can Inst. 88:1996;890-899.
35. Byers R.M. Modified neck dissection a study of 967 cases from 1970-1980 . Am J Surg. 150:1980;414-421.
36. Medina J.E., Byers R.M. Supraomohyoid neck dissection rationale, indications and surgical technique . Head Neck. 11:1989;111-122.
37. Golomb H.M., Catovsky D., Golde D.W. Hairy cell leukemia a clinical review based on 71 cases . Ann Intern Med. 89:1978;677-683.
38. Golomb H.M., Vardiman J.W. Response to splenectomy in 65 patients with hairy cell leukemia an evaluation of spleen weight and bone marrow involvement . Blood. 61:1983;349-352.
39. Quesada J.R., Hersh E.M., Manning J., et al. Treatment of hairy cell leukemia with recombinant alpha interferon. Blood. 68:1985;493-497.
40. Piro L.D., Carrera C.J., Carons D.A., Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. NEJM. 322:1990;1117-1121.
41. Estey E.H., Kurzrock R., Kantarjian H.M., et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood. 79:1992;882-887.
42. Nigro N.D., Vaitkevicius V.K., Considine B. Jr. Combined therapy for cancer of the anal canal a preliminary report . Dis Colon Rectum. 17:1974;354-356.
43. Leichman L., Nigro N., Vaitkeviceus V.K., et al. Cancer of the anal canal model for preoperative adjuvant combined modality therapy . Am J Med. 78:1985;211-216.
44. Enker W.E., Heilweil M., Janov A.J., et al. Improved survival in epidermoid carcinoma of the anus in association with pre-operative multi-disciplinary therapy. Arch Surg. 121:1986;1386-1390.
45. Cummings B.J., Keane T.J., O'Sullivan V., Wong C.S., Catton C.N. Epidermoid anal cancer treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C . Int J Radiat Oncol Biol Phys. 21:1991;1115-1125.
46. Graham R.A., Garnsey L., Jessup J.M. Local excision of rectal carcinoma. Am J Surg. 106:1990;306-312.
47. Jessup J.M., Bleday R., Busse P., et al. Conservative management of rectal carcinoma the efficacy of a multimodality approach . Semin Surg Oncol. 9:1993;39-45.
48. Veronesi U., Cascinelli N., Adamus J., et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. NEJM. 318:1988;1159-1162.
49. Balch C.M., Urist M.M., Karakousis C.P., et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial. Ann Surg. 218:1993;262-267.
50. Veronesi U., Adams J., Bandiera D.C., et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 49:1982;2420-2430.
51. Sim F.H., Taylor W.F., Prichard D.J., et al. Lymphadenectomy in the management of stage I malignant melanoma a prospective randomized study . Mayo Clinic Proc. 61:1986;697-705.
52. Balch C.M., Milton G.W., Cascinelli N., Milton G.W., Sim F.H. Elective node dissection: pros and cons. Balch C.M., Houghton A.N., Milton G.W., Sober A., Soong S-j. Cutaneous Melanoma. 2nd ed. 1992;345 JF Lippincott, Philadelphia.
53. Balch C.M., Soong S., Bartolucci, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm. thick melanomas for patients 60 years of age and younger. Ann Surg. 224:1996;255-266.
54. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 127:1992;392-399.
55. Ross M.I., Reintgen D.L., Balch C.M. Selective lymphadenectomy emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma . Semin Surg Oncol. 9:1993;219-223.
56. Kirkwood J.M., Strawderman M.H., Ernstoff M.S., et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma the Eastern Cooperative Oncology Group Trial EST 1684 . J Clin Oncol. 14:1996;7-17.
57. Shields J.A., Shields C.S. Current management of posterior uveal melanoma. Mayo Clin Proc. 68:1993;1196-1200.
58. Morton R.A., Steiner M.S., Walsh P.C. Cancer control following anatomical radical prostatectomy an interim report . J Urol. 145:1991;1197-1200.
59. Kavoussi L.R., Sosa E., Chankhoke P., et al. Complications of laparoscopic pelvic lymph node dissection. J Urol. 149:1993;322-325.
60. Bahn D.K., Lee F., Solomon M.H., Gontina H., Klionsky D.L., Lee F.T. Jr. Prostate cancer: ultrasound-guided percutaneous cryoablation. Work in progress. Radiology. 194:1995;551-556.
61. Onik G.M., Cohen J.K., Reyes G.H., Rubinsky B., Chang Z., Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 72:1993;1291-1299.
62. D'Amico A.V., Coleman N.C. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer the jury is still out . J Clin Oncol. 14:1996;304-315.
63. Catalona W.J. Drug therapy management of cancer of the prostate . NEJM. 331:1994;996-1004.
64. Conn P.M., Crowley W.F. Jr. Gonadotropin-releasing hormone and its analogues. NEJM. 324:1991;93-103.
65. Parmar H., Phillips R.H., Lightman S.L., Edwards L., Allen L., Schally A.V. Randomised controlled study of orchiedectomy vs. long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma. Lancet. 2:1985;1201-1205.
66. Tester W., Porter A., Asbell S., et al. Combined modality program with possible organ preservation for invasive bladder carcinoma results of RTOG protocol 85-12 . Int J Radiat Oncol Biol Phys. 25:1993;783-790.
67. Tester W., Caplan R., Heane J., et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer results of Radiation Therapy Oncology Group Phase II Trial 8802 . J Clin Oncol. 14:1996;119-126.
68. Kaufman D.S., Shipley W.U., Griffin P.P., Henely N.M., Althausen A.F., Efird U. Selective bladder preservation by combination treatment of invasive bladder cancer. NEJM. 329:1993;1377-1382.
69. Rowland R.G., Mitchell M.E., Bihrle R., et al. Indiana continent urinary reservoir. J Urol. 137:1987;1136-1139.
70. Lowe B.A. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors. Urol Clin N Am. 20:1993;75-83.
71. Johnson D.E., Lo R.K., von Eschenbach A.C., et al. Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis preliminary results . J Urol. 131:1984;491-493.
72. Pizzocaro G., Zanoni F., Milani A., et al. Orchiectomy alone in clinical stage I nonseminomatous testis cancer; a critical appraisal. J Clin Oncol. 4:1986;35-40.
73. Richie J.P. Clinical stage I testicular cancer the role of modified retroperitoneal lymphadenectomy . J Urol. 144:1990;1160-1163.
74. Logothetis C.J., Swanson D.A., Dexeus F., et al. Primary chemotherapy for clinical stage II nonseminamatous germ cell tumors of the testis a follow-up of 50 patients . J Clin Oncol. 5:1987;906-911.
75. Lerner S.E., Mann B.S., Blute M.L., Richardson R.L., Zincke H. Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors selection criteria and long term results . Mayo Clin Proc. 70:1995;821-828.
76. Rosenberg S.A., Tepper J., Glatstein E., et al. The treatment of soft tissue sarcoma of the extremities. Ann Surg. 196:1982;305-314.
77. Brennan M.F., Casper E.S., Harrison L.K., et al. The role of multimodality therapy in soft-tissue sarcoma. Ann Surg. 214:1991;328-338.
78. Malawer M.M., Link M.P., Donaldson S.S. Sarcomas of Bone. DeVita V.T. Jr, Hellman S., Rosenberg S.A. Cancer Principles and Practice of Oncology . 4th ed. 1993;1509-1566 JB Lippincott.
79. Eilber F., Giuliano A., Eckardt J., et al. Adjuvant chemotherapy for osteosarcoma; a randomized prospective trial. J Clin Oncol. 5:1987;21-26.
80. Soper N.J., Brunt L.M., Kerbl K. Laparoscopic general surgery. NEJM. 330:1994;409-419.
81. Greene F.L. Larparoscopy in malignant disease. Surg Clin North Am. 72:1992;1125-1137.
82. Ota D.M., Nelson H., Weeks J.C. Controversies regarding laparoscopic colectomy for malignant diseases. Curr Opin Gen Surg. 1994;208-213.
83. Johnstone P.A.S., Rohde D.C., Swartz S.E., Getter J.E., Wexner S.D. Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy. J Clin Oncol. 14:1996;1950-1956.
84. Landreneau R.J., Mack M.J., Hazelrigg S.R., Naunheim K.S., Keenan R.J., Ferson P.F. The role of video-assisted thoracic surgery in thoracic oncological practice. Canc Invest. 13:1995;526-539.
85. Alexander E. III, Moriarty T.M., Davis R.B., et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Nat Canc Inst. 87:1995;34-40.
86. Phillips M.H., Stelzer K.J., Griffin T.W., Mayberg M.R., Winn H.R. Stereotactic radiosurgery a review and comparison of methods . J Clin Oncol. 23:1994;1085-1099.
87. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. NEJM. 322:1990;494-500.
88. Ponsky J.L., Gauderer M.W.L. Percutaneous endoscopic gastrostomy a non-operative technique for feeding gastrostomy . Gastrointest Endosc. 27:1981;9-11.
89. Speer A., Russell R.C.G., Hatfield A., et al. Randomized trial of endoscopic vs. percutaneous stent insertion for malignant obstructive jaundice. Lancet. ii:1987;57-61.
90. Andrews J.C., Marx M.J., Williams D.M., et al. The upper arm approach for placement of peripherally inserted central catheters for protracted venous access. Am J Roentgenol. 158:1992;427-429.
91. Kyle K.S., Myers J.S. Peripherally inserted central catheters development of a hospital-based program . J Intraven Nurs. 13:1989;287-290.
92. Dorfman G.S. Percutaneous inferior vena cava filters. Radiology. 174:1990;987-992.
93. Sanders M., Zuurmond W. Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients. J Clin Oncol. 13:1995;1509-1512.
94. Ajani J.A., Carrasco C.H., Charnsangavej C., et al. Islet cell tumors metastatic to the liver effective palliation by sequential hepatic artery embolization . Ann Intern Med. 108:1988;340-344.
95. Charnsangavej C. Chemoembolization of liver tumors. Semin Invest Radiol. 10:1993;150-160.
96. Frucht H., Maton P., Jensen R.T. The use omeprazole in patients with Zollinger-Ellison syndrome. Dig Dis Sci. 36:1991;394-404.
97. Herskovic A., Martz L., Al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. NEJM. 326:1992;1593-1598.
98. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. NEJM. 323:1990;940-945.